| Literature DB >> 14575897 |
Henya C Grossman1, Maria M Hadjimarkou, Robert M Silva, Silvia Q Giraudo, Richard J Bodnar.
Abstract
The present study examined the interrelationships between feeding responses produced by mu opioid receptor agonists and melanocortin-3 or 4 (MC-3/4) receptor antagonists. Feeding induced by the mu-sensitive opioid peptide, beta-endorphin (betaEND, 10 microg, i.c.v.) was significantly and dose-dependently reduced by pretreatment with the MC-3/4 receptor agonist, melanotan-II (MTII: 0.01-10 nmol, i.c.v.). Moreover, the selective mu opioid antagonist, beta-funaltrexamine (betaFNA: 2-20 mug, i.c.v.), significantly and dose-dependently reduced feeding and weight gain elicited by the potent MC-3/4 receptor antagonist, SHU-9119 (0.5 nmol, i.c.v.), especially at those intake periods (24-48 h) when SHU-9119 produced maximal ingestive effects. These data extend previous findings demonstrating interactions between opioid and melanocortin receptors in the mediation of food intake.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14575897 DOI: 10.1016/s0006-8993(03)03442-5
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252